‘Limited’ stocks at Rs 600, says Serum; Centre says our price remains Rs 150 – The Indian Express
- ‘Limited’ stocks at Rs 600, says Serum; Centre says our price remains Rs 150 The Indian Express
- Serum Institute On “Inaccurate” Comparison Amid Row Over Vaccine Prices NDTV
- COVID-19: Can India salvage the situation? Here’s what it is doing The Financial Express
- The economic case for free vaccination for all Mint
- Serum Institute’s Rs 600/dose for Covishield in private hospitals is its highest rate the world over The Indian Express
- View Full coverage on Google News